The U.S. Food and Drug Administration (FDA) held a public meeting on May 1, 2009, to receive public input on the issue of intentional adulteration motivated by economic gain. Several high profile instances of adulteration (i.e., melamine in pet food and infant formula, contaminated Heparin, toothpaste and cough syrup contaminated with diethylene glycol) has prompted FDA to study parameters that could be used to predict and thus prevent future situations of economically motivated adulteration (EMA). NFI testified on the panel of food and feed industry associations to describe the actions that NFI members are taking to address fraud in the industry through the Better Seafood Board and our belief that FDA can prevent situations of EMA by enforcing all situations of fraud, regardless of the risk to public health.